BIOMARKERS

Molecular Biopsy of Human Tumors

Biomarkers for Kidney tumors

1. VHL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
2. IL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
3. TP53
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
4. WT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
5. MTOR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
6. POLE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
7. NR4A3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
8. EGFR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
9. ESR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
10. AKT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
11. PR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
12. MYC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
13. TSC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
14. BCL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
15. CDKN2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
16. KDR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
17. ER
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
18. FBXW7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
19. FH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
20. Ki-67
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
21. KIT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
22. U2AF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
23. PRCC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
24. HIF1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
25. TSC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
26. AR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
27. MUC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
28. ERBB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
29. MAPK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
30. TFE3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
31. PIK3CA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
32. CTLA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
33. TIMP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
34. PSA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
35. SMARCB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
36. FLCN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
37. CEACAM5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
38. FGFR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
39. PTEN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
40. FAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
41. SRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
42. MS4A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
43. ROS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
44. APC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
45. ITK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
46. SDHB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
47. JUN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
48. PDCD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
49. TG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
50. MET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
51. CD79A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
52. CALCB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
53. LDH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
54. FUS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
55. GNAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
56. STAT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
57. PAX8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
58. SPEN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
59. BRCA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
60. MAX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
61. PTPRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
62. RB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
63. ENO2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
64. AFP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
65. CD274
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
66. MLH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
67. MYCN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
68. RHOA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
69. FHIT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
70. CALR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
71. HRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
72. MDM2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
73. ABCG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
74. RET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
75. CXCR4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
76. SERPINE1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
77. ABL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
78. EWSR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
79. MSH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
80. PDGFRB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
81. hCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
82. CDKN1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
83. PBRM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
84. ABL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
85. CCDC6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
86. TP63
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
87. ALK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
88. BCR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
89. DDIT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
90. FOXP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
91. TFEB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
92. MEN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
93. BAP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
94. BRD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
95. SETD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
96. MUC16
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
97. HLA-A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
98. PRKAR1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
99. NTRK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
100. uPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
101. CTNNB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
102. FANCA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
103. RAF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
104. KRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
105. MITF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
106. PRF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
107. ATM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
108. AMER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
109. CDC73
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
110. STIL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
111. CLIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
112. NFE2L2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
113. PPFIBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
114. RHOH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
115. BRAF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
116. CCND1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
117. POU5F1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
118. ARID1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
119. GOPC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
120. NCKIPSD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
121. CREBBP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
122. SSX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
123. CDK4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
124. PTCH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
125. SDHA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
126. TERT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
127. NKX2-1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
128. SMAD3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
129. RARA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
130. SDHD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
131. SS18
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
132. CUX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
133. EZH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
134. MDM4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
135. RAC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
136. BLM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
137. SFPQ
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
138. SMAD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
139. GATA3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
140. CgA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
141. BRCA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
142. DICER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
143. EP300
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
144. JAK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
145. KDM5C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
146. SDHC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
147. ETV6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
148. HSP90AA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
149. KMT2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
150. NF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
151. NRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
152. PML
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
153. FLT4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
154. KLK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
155. MSH6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
156. YWHAE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
157. NOTCH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
158. NTRK3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
159. SMARCA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
160. Beta-hCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
161. CDH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
162. PMS2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
163. ARID1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
164. GPC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
165. EPAS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
166. PDGFB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
167. FLI1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
168. FLT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
169. KDM6A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
170. MAP2K1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
171. NONO
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
172. ARNT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
173. CTCF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
174. ERG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
175. IL6ST
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
176. STK11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
177. ELN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
178. NT5C2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
179. RECQL4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
180. STAT5B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
181. CDX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
182. DROSHA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
183. CASP8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
184. CHEK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
185. FES
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
186. JAK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
187. JAK3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
188. NBN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
189. NF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
190. PTK6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
191. REL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
192. ZNF331
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
193. Nuclear matrix protein 22
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
194. BIRC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
195. CDK6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
196. ERBB4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
197. KEAP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
198. PDCD1LG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
199. SMO
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
200. ERBB3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
201. FGFR3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
202. TCF7L2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
203. CYP2D6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
204. ASPSCR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
205. BCOR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
206. CBL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
207. CDKN2C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
208. CIC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
209. CRTC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
210. HMGA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
211. IDH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
212. IL7R
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
213. LCK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
214. LMNA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
215. PDGFRA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
216. PTPN11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
217. TOP2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
218. AXIN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
219. DNMT3A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
220. ELF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
221. ETV4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
222. FGFR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
223. KLF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
224. MAF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
225. MALAT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
226. MYB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
227. SMAD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
228. CYLD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
229. EBF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
230. HNF1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
231. KMT2D
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
232. MYOD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
233. NDRG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
234. PAX3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
235. SOX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
236. SPECC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
237. SSX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
238. TCF3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
239. WIF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
240. CD74
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
241. CLTC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
242. FEV
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
243. FOXO3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
244. HEY1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
245. NUTM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
246. NUTM2B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
247. PPM1D
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
248. RPL22
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
249. SALL4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
250. STAT6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
251. TAL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
252. TMPRSS2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
253. TPR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
254. AKT2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
255. B2M
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
256. CCNE1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
257. CDH11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
258. ERCC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
259. ETV5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
260. FOXO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
261. IGH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
262. KLF6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
263. RPL10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
264. RUNX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
265. TFRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
266. TOP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
267. TSHR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
268. XPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
269. ATR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
270. BUB1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
271. CCND2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
272. CREB3L1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
273. EXT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
274. FOXA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
275. FOXP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
276. FUBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
277. LEF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
278. NOTCH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
279. WFDC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
280. AXIN2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
281. CIITA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
282. DDR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
283. DDX5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
284. FANCC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
285. FANCD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
286. FGFR4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
287. HERPUD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
288. IDH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
289. LCP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
290. MALT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
291. NIN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
292. NPM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
293. PAX5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
294. RNF43
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
295. SEPT9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
296. TNFRSF17
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
297. TPM3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
298. WAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
299. ZNF198
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
300. CD52
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
301. ACVR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
302. ALDH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
303. ARHGAP26
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
304. BCL10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
305. BCL6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
306. CARS
    [Clinical Outcome] [Diagnosis] [